- Home
- ORIC vs SGML Comparison
ORIC vs SGML Comparison
Compare ORIC & SGML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORIC | SGML |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ORIC | SGML |
|---|---|---|
| Price | $12.55 | $8.34 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 4 |
| Target Price | ★ $21.08 | $11.33 |
| AVG Volume (30 Days) | 1.2M | ★ 1.8M |
| Earning Date | 11-12-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 19.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $109.04 |
| Revenue Next Year | N/A | $109.81 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.23 | $4.62 |
| 52 Week High | $14.93 | $24.48 |
Technical Indicators
Market Signals| Indicator | ORIC | SGML |
|---|---|---|
| Relative Strength Index (RSI) | 57.13 | 36.00 |
| Support Level | $13.12 | N/A |
| Resistance Level | $14.22 | $13.22 |
| Average True Range (ATR) | 0.69 | 0.50 |
| MACD | 0.06 | -0.05 |
| Stochastic Oscillator | 73.36 | 0.75 |
Price Performance
Historical ComparisonAbout ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About SGML Sigma Lithium Corporation
Sigma Lithium Corp together with its direct and indirect subsidiaries, is a commercial producer of lithium concentrate. It holds full interest in four mineral properties: Grota do Cirilo, Sao Jose, Santa Clara, and Genipapo, located in the municipalities of Aracuai and Itinga, in the Vale do Jequitinhonha region in the State of Minas Gerais, Brazil. Geographically, the company operates in Switzerland; United Arab Emirates; Singapore; and Republic of Korea, of which it derives maximum revenue from Switzerland.